Answers are grounded in this paper and cite their sources.
Childhood CB is rare in southern Israel. The disease manifests as a single gastroenteritis complication in a previously healthy young child or as recurrent episodes in an older, immune-compromised child, usually without gastrointestinal symptoms. This disparity may reflect pathogenesis differences, with disease in the immune-competent being dependent on pathogen virulence, whereas disease in the immune-compromised being host dependent. Disease outcome is usually favorable, and macrolides remain the antibiotic treatment of choice.
No takes yet. Share an insight, caveat, or question.
Ben‐Shimol et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: